SCHEMBL19638083

SCHEMBL19638083

COc1ccc(-c2nc(NC(=O)c3ccccc3C(=O)O)sc2C#N)cc1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DDX3X O00571 3/20 0.62
KMT2A Q03164 4/20 0.57
ADORA3 P0DMS8 6/20 0.54
ADORA2A P29274 3/20 0.54
MAPT P10636 4/20 0.53
MEN1 O00255 3/20 0.53
ALDH1A1 P00352 2/20 0.53
ADORA1 P30542 6/20 0.53
LMNA P02545 2/20 0.51
RAB9A P51151 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
USP2 O75604 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
POLB P06746 1/20 0.49
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19637998 0.85 ADORA3 (0.54) KMT2AADORA3ADORA2AMAPTMEN1
SCHEMBL19638140 0.85 ADORA3 (0.63) KMT2AADORA3ADORA2AMAPTMEN1
SCHEMBL19638094 0.84 ADORA3 (0.55) KMT2AADORA3ADORA2AMAPTMEN1
SCHEMBL17951287 0.84 ADORA3 (0.57) KMT2AADORA3ADORA2AMAPTMEN1
SCHEMBL19638038 0.79 ADORA3 (0.51) KMT2AADORA3ADORA2AMAPTMEN1
SCHEMBL30309274 0.77 ADORA3 (0.65) KMT2AADORA3ADORA2AMAPTMEN1
SCHEMBL22331559 0.77 ADORA3 (0.65) KMT2AADORA3ADORA2AMAPTMEN1
SCHEMBL19637975 0.75 ADORA2A (0.66) KMT2AADORA3ADORA2AALDH1A1ADORA1
SCHEMBL19638040 0.75 ADORA2A (0.60) KMT2AADORA3ADORA2AMAPTMEN1
SCHEMBL19638387 0.75 ADORA3 (0.57) KMT2AADORA3ADORA2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107207445-B Adenosine A3Modulators of receptors 帕罗生物制药有限公司 2021-03-16 CN claimed
EP-3248964-B1 THIAZOLE MODULATORS OF A3 ADENOSINE RECEPTORS PALOBIOFARMA SL (ES) 2019-07-17 EP claimed
US-10238637-B2 Modulators of the adenosine A3 receptors PALOBIOFARMA, S.L. (ES) 2019-03-26 US claimed
US-20180263963-A1 MODULATORS OF THE ADENOSINE A3 RECEPTORS PALOBIOFARMA, S.L. (ES) 2018-09-20 US claimed
EP-3248964-A1 THIAZOLE MODULATORS OF A3 ADENOSINE RECEPTORS PALOBIOFARMA S.L. (ES) 2017-11-29 EP claimed
CN-107207445-B Adenosine A3Modulators of receptors 帕罗生物制药有限公司 2021-03-16 CN disclosed
EP-3248964-B1 THIAZOLE MODULATORS OF A3 ADENOSINE RECEPTORS PALOBIOFARMA SL (ES) 2019-07-17 EP disclosed
US-10238637-B2 Modulators of the adenosine A3 receptors PALOBIOFARMA, S.L. (ES) 2019-03-26 US disclosed
US-20180263963-A1 MODULATORS OF THE ADENOSINE A3 RECEPTORS PALOBIOFARMA, S.L. (ES) 2018-09-20 US disclosed
EP-3248964-A1 THIAZOLE MODULATORS OF A3 ADENOSINE RECEPTORS PALOBIOFARMA S.L. (ES) 2017-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180263963-A1 MODULATORS OF THE ADENOSINE A3 RECEPTORS ADORA3, ADORA2A, ADORA1 DDX3X 762/4885KMT2A 4093/4885ADORA3 1/4885
US-10238637-B2 Modulators of the adenosine A3 receptors ADORA3, ADORA2A, ADORA1 DDX3X 762/4885KMT2A 4093/4885ADORA3 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.